Hepion Pharmaceuticals, Inc.
เพิ่มขึ้น
ที่อัปเดต:

Extremely undervalued

Overreaction to their public offering. Their cash balance would already be higher than their market cap once the offering is closed.
บันทึก
Have closed the position for other trades

คำจำกัดสิทธิ์ความรับผิดชอบ